1. 355 First-in-human phase I study of NKTR-255 in patients with relapsed/refractory hematologic malignancies. (10th December 2020) Authors: Shah, Nina; Tan, Alan; Budde, Lihua; Hofmeister, Craig; Cowan, Andrew; Saeed, Hayder; Ye, Jing; Cairo, Mitchell; Rizzieri, David; Orloff, Gregory; Ge, Xue Snow; Lee, Zachary; Dixit, Neha; Nieves, Wildaliz; Vimal, Mona; Ma, Haijun; Miyazaki, Takahiro; Madakamutil, Loui; Marcondes, Mario; Lin, Wei Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma. (25th April 2017) Authors: Batlevi, Connie L.; Crump, Michael; Andreadis, Charalambos; Rizzieri, David; Assouline, Sarit E.; Fox, Susan; van der Jagt, Richard H. C.; Copeland, Amanda; Potvin, Diane; Chao, Richard; Younes, Anas Journal: British journal of haematology Issue: Volume 178:Number 3(2017) Page Start: 434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma. (19th March 2013) Authors: Held, Lauren A.; Rizzieri, David; Long, Gwynn D.; Gockerman, Jon P.; Diehl, Louis F.; Castro, Carlos M. de; Moore, Joseph O.; Horwitz, Mitchell E.; Chao, Nelson J.; Gasparetto, Cristina Journal: Cancer investigation Issue: Volume 31:Number 3(2013) Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase II study of elacytarabine in combination with idarubicin and of human equilibrative nucleoside transporter 1 expression in patients with acute myeloid leukemia and persistent blasts after the first induction course. Issue 9 (September 2014) Authors: Rizzieri, David; Vey, Norbert; Thomas, Xavier; Huguet-Rigal, Françoise; Schlenk, Richard F.; Krauter, Jürgen; Kindler, Thomas; Gjertsen, Bjørn Tore; Blau, Igor Wolfgang; Jacobsen, Tove Flem; Johansen, Malin; Bergeland, Trygve; Gianella-Borradori, Athos; Krug, Utz Journal: Leukemia & lymphoma Issue: Volume 55:Issue 9(2014:Sep.) Page Start: 2114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study. (August 2020) Authors: Goldberg, Aaron D.; Atallah, Ehab; Rizzieri, David; Walter, Roland B.; Chung, Ki-Young; Spira, Alexander; Stock, Wendy; Tallman, Martin S.; Cruz, Hans G.; Boni, Joseph; Havenith, Karin E.G.; Chao, Grace; Feingold, Jay M.; Wuerthner, Jens; Solh, Melhem Journal: Leukemia research Issue: Volume 95(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkin''s lymphoma. (January 2012) Authors: Beaven, Anne W; Rizzieri, David Journal: Clinical investigation Issue: Volume 2:Number 1(2012) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma. (16th March 2023) Authors: Lin, Chenyu; Galal, Ahmed; Rizzieri, David; Chawla, Sant; Lee, Seung T.; Georgy, Angela; Dabovic, Kristina; Strack, Thomas; McKinney, Matthew Journal: Cancer investigation Issue: Volume 41:Number 3(2023) Page Start: 253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States. Issue 4 (21st October 2020) Authors: Hong, Sanghee; Brazauskas, Ruta; Hebert, Kyle M.; Ganguly, Siddhartha; Abdel‐Azim, Hisham; Diaz, Miguel Angel; Beattie, Sara; Ciurea, Stefan O.; Szwajcer, David; Badawy, Sherif M.; Gratwohl, Alois A.; LeMaistre, Charles; Aljurf, Mahmoud D. S. M.; Olsson, Richard F.; Bhatt, Neel S.; Farhadfar, Nos... Journal: Cancer Issue: Volume 127:Issue 4(2021) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cyclophosphamide‐based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma. Issue 3 (8th October 2014) Authors: Tuchman, Sascha A; Bacon, Wendi A; Huang, Li‐Wen; Long, Gwynn; Rizzieri, David; Horwitz, Mitchell; Chute, John P.; Sullivan, Keith; Morris Engemann, Ashley; Yopp, Amanda; Li, Zhiguo; Corbet, Kelly; Chao, Nelson; Gasparetto, Cristina Journal: Journal of clinical apheresis Issue: Volume 30:Issue 3(2015) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia. Issue 2 (6th December 2017) Authors: Roboz, Gail J.; Kantarjian, Hagop M.; Yee, Karen W. L.; Kropf, Patricia L.; O'Connell, Casey L.; Griffiths, Elizabeth A.; Stock, Wendy; Daver, Naval G.; Jabbour, Elias; Ritchie, Ellen K.; Walsh, Katherine J.; Rizzieri, David; Lunin, Scott D.; Curio, Tania; Chung, Woonbok; Hao, Yong; Lowder, James... Journal: Cancer Issue: Volume 124:Issue 2(2018) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗